Skip to main content
PLOS Neglected Tropical Diseases logoLink to PLOS Neglected Tropical Diseases
. 2025 Jan 31;19(1):e0012830. doi: 10.1371/journal.pntd.0012830

Genomic characterization of antimicrobial-resistance and virulence factors in Salmonella isolates obtained from pig farms in Antioquia, Colombia

María Isabel García-Álvarez 1, Juana L Vidal 2, Pilar Donado-Godoy 3, Jared Smith 4, Nikki Shariat 4, María Fernanda Valencia 3, Luis M Gómez-Osorio 1, Sara López-Osorio 1, Jenny J Chaparro-Gutiérrez 1,*
Editor: Ahmed Hassan Fahal5
PMCID: PMC11801710  PMID: 39888971

Abstract

Background

Occurrence of antimicrobial-resistant Salmonella strains has been reported worldwide, because of inappropriate use of antimicrobial products in either humans or animals. The presence of multidrug resistant Salmonella in pig production systems had been reported in Antioquia, Colombia.

Aim

To identify antimicrobial resistance genes (ARG) in different Salmonella spp. strains isolated from pig productions in Antioquia, Colombia. Methods: Samples were received at the Diagnostic Unit of the Faculty of Agrarian Sciences at the University of Antioquia, from January 1, 2019, to January 2021. A total of 28 isolates of Salmonella spp. were included, which presented phenotypic resistance to more than one antibiotic used in pig farms. Whole genome sequencing (WGS) was performed in the Unit of Genomic of Agrosavia using an automated pipeline from the GHRU- Sanger Institute, employing the Illumina MiSeq platform.

Results

WGS revealed 34 ARGs among these isolates. In 25 isolates (89%) more than two ARGs were found. Genes encoding resistance were found for 10 different groups of antibiotics (beta-lactam, aminoglycosides, chloramphenicol, rifampicins, lincosamides, fluoroquinolones, tetracyclines, sulfonamides and trimethoprim). The most frequently observed MDR profile in Typhimurium isolates was AMP-CEX-CEP-CEF-EFT-CEQ-FLU-ENR-TE-FFC-SXT.

Conclusion

The presence of multi-drug resistant Salmonella strains in pigs destined for human consumption in Antioquia, Colombia was determined. This research emphasizes the utmost importance of epidemiological tools to understand the presence and spreading of antimicrobial resistance genes in pig farms. Additionally, it highlights the critical need for developing educational programs and public policies to help reduce the spread of antimicrobial resistance in production systems.

Author summary

Recent research has raised alarms about antimicrobial resistance in Salmonella found in pigs from farms in Antioquia, Colombia. We used whole-genome sequencing to identify 34 resistance genes in 28 Salmonella isolates, revealing that 89% of these isolates carried more than two resistance genes, affecting various antibiotics. This situation poses significant risks, as multidrug-resistant Salmonella in pigs could directly or indirectly impact human health and lead to potential economic losses in pig production.

Our findings highlight the urgent need to implement better management practices on farms and responsible antibiotic use in pig production. Properly addressing these issues is essential to ensure food safety and protect public health. Continuous surveillance and effective control measures are crucial to combat this growing problem. By prioritizing these actions, we can help mitigate the risks associated with antimicrobial resistance and safeguard both livestock and consumers.

Introduction

The increased incidence of Salmonella spp. has a significant impact on public and animal health [1]. Human salmonellosis has been mainly associated with food animal production (beef, pork, chicken, and eggs) [2]. Globally, Salmonella serovar Typhimurium and its monophasic variant, serovar I 4, [3], 12:i:-, are responsible for the high incidence of human illness [4] and both serovars are commonly associated with swine.

There are nearly 10 million pigs in Colombia, 89.5% of which are from industrial production farms, while the remaining 10.5% are from smaller operations [5]. It is estimated that the consumption per capita of pork in Colombia in 2021 was 12.2 kg, and over 500 tons are produced in Colombia each year [3]. Exports for this same year reached around 100 tons of pork destined for the Ivory Coast and Hong Kong [6]. For 2021, official figures report a profit of 5,536,335 swine heads with an increase of 6.6% compared to the previous year [7]. The Antioquia region of Colombia is considered the largest producer of pork in the country and is responsible for ~11% of the swine inventory [8].

The occurrence of antimicrobial-resistant Salmonella infections has been reported globally [9]. Human Salmonella infections caused by antibiotic-resistant strains have been associated with severe disease and more significant adverse outcomes, including increased rate of hospitalizations, longer length of hospital stays, and higher mortality [10]. In swine, antimicrobial agents are critical in treating serious infections such as salmonellosis, colibacillosis, and mycoplasmal pneumonia [11]. However, in many developing countries, antimicrobials are used in swine and other food animal production for non-clinical purposes, e.g., as feed proficiency enhancers and growth promoters [12], which, added to the ease of obtaining antibiotics in the country, has resulted in an overuse of antimicrobials [13].

Recently, antimicrobial resistance (AMR) in Salmonella isolates from pig production in Colombia was demonstrated, presenting multidrug resistance (resistance to ≥ 3 classes of antibiotics) in 44% of isolates [14]. These results underline how crucial it is to comprehend the dynamics of antimicrobial usage in pig production and to assess the rise of Salmonella resistance in Antioquia. This information is critically needed to improve judicious antimicrobial usage in the livestock sector [14,15]. Additionally, this knowledge is required to inform veterinarians, managers, and employees of piggeries on the cautious use of antibiotics to maintain pig disease susceptibility, which will benefit the consumer and may lead to a reduced production costs related to ailments brought on by AMR bacteria and their treatment [16].

This study aimed to genomically characterize antimicrobial resistance and virulence factors in Salmonella spp. isolates from pig productions in Antioquia, Colombia. Furthermore, a comparative analysis was conducted between phenotypic resistance profiles and their corresponding genotypic attributes.

Materials and methods

Endorsement of the Ethics Committee

The Ethics Committee for Animal Experimentation (CEEA) of the Universidad de Antioquia granted the ethical endorsement to perform this study according to minute No. 141 of August 3, 2021.

Sample collection and Salmonella isolation

A total of 28 Salmonella spp. isolates were included. These were recovered from fecal samples, rectal swabs, and intestinal tissue samples from commercial pig farms in the department of Antioquia, Colombia. The samples were received at the Diagnostic Unit of the Faculty of Agrarian Sciences at the University of Antioquia, Colombia. The samples arrived at the laboratory routinely, and the inclusion period extended from January 1, 2019, to January 2021, during which they were preserved and processed.

Isolation and identification

In brief, 10-25 g of feces and gut tissue samples were transferred to 225 mL of buffered peptone (BPW) water, and 9 mL of BPW was added to rectal swabs. Samples were homogenized for 2 minutes and incubated at 35 °C for 18-24 hours. For selective enrichment, 100 μL were inoculated in 10 mL of Rappaport-Vassiliadis broth, and then incubated at 42 °C for 18 to 24 hours. After incubation, broth cultures were plated on Hektoen agar and xylose lysine deoxycholate agar (XLD) and incubated at 35 °C for 18-24 hours. Blue or blue-green colonies (with or without black center) on Hektoen agar and transparent to pinkish-red colonies (with or without black center) on XLD were presumptive. These presumptive positive colonies underwent biochemical tests (TSI, LIA, citrate, and SIM) and serological tests (Check and Trace Salmonella) for Salmonella confirmation [1719].

Identification of presumptive bacterial isolates and antimicrobial susceptibility testing

Salmonella spp. isolates from pigs were sent to the Global Health Research Unit- Colombia (Corporación Colombiana de Investigación Agropecuaria (AGROSAVIA), CI Tibaitatá, Mosquera, Colombia) to be sequenced (Table 1). The presumptive Salmonella isolates were evaluated for identification and antibiotic susceptibility testing using the Vitek2 Compact System with GN ID and AST-N272 cards (BioMerieux, Lyon, France) according to the manufacturer’s instructions. Minimum inhibitory concentration (MIC) was interpreted according to Clinical and Laboratory Standards Institute (CLSI) 2020 guidelines [20].

Table 1. Resistance patterns found in 28 Salmonella isolates from commercial swine farms in the Antioquia, Colombia.

Serotype(s) No. Of Isolates AMPa CEXb CEPc CEFd CFPZe GENf CEQg FLUh ENRi TEj FFCk SXTl MARm NEOn
Typhimurium 5
I, 4, [3],12: i: - 3
I, 4, [3],12: i: - 2
Altona 1
I, 4, [3],12: i: - 3
I, 4, [3],12: i: - 3
I, 4, [3],12: i: - 2
Altona 1
Altona 1
I, 4, [3],12: i: - 1
Typhimurium 1
I, 4, [3],12: i: - 1
Typhimurium 1
Typhimurium 1
Typhimurium 1
Typhimurium 1

a: ampicillin, b: cefalexin, c: cephalothin, d: ceftiofur, e: cefoperazone, f: gentamicin, g: cefquinome, h: flumequine, i: enrofloxacine, j: tetracycline, k: florfenicol, l: trimethoprim, m: marbofloxacine, n: neomicyn.

Whole Genome Sequencing

An overnight culture from a single colony of each Salmonella isolate was prepared in 1 ml of lysogeny broth (LB). The DNA from each Salmonella isolate was extracted using the PureLink Genomic DNA Mini Kit (Invitrogen, USA) according to the manufacturer’s instructions. The purity was assessed by measuring the absorbance ratio at OD 260/280 NanoDrop (Thermo Fisher Scientific), and the yield was established with a Qubit 4.0 Fluorometer (Thermo Fisher Scientific, USA). The library preparation was made using NEBNext Ultra II FS DNA Library Prep with Sample Purification Beads (New England Biolabs, UK) according to the manufacturer’s instructions. Immediately, libraries were pooled, quantified, and normalized down to 4nM using the Tape Station System (Agilent, USA). Subsequently, the denaturation library was loaded onto an Illumina MiSeq (San Diego, USA) reagent cartridge using a reagent kit v2 and 300 cycles (150 bp paired-end sequencing) with a Standard Flow Cell. All isolates sequenced had a 50X coverage, <=150 contigs, an average GC content of 51%, an N50 score >50000, and a total assembly length between 4.5–5.2 Mega base pairs (Mbp).

Genome analysis

The sequencing products were processed using an automatic pipeline from GHRU - The Centre for Genomic Pathogen Surveillance (https://gitlab.com/cgps/ghru/pipelines). The first pipeline is for assembly and includes the read quality assessed with FastQC v0.11 [21], identification of species with BactInspector v0.1.3 [22] and contamination using Confidr v0.7.2 [23]. The sequences were trimmed and assembled using Trimommatic v0.39 [24], Mash v2.2 [25], Seqtk v1.3 [26], FLASH v1.2.1 [27], Ligther v1.1 [28], and SPAdes v3.14.0. [29], in that order. The assembly’s quality was determined with the software Quast v5.0.2 [30]. All running parameters were set as default, expect trimommatic min_length, set as 30% of raw reads size, all databases in docker containers, as described in the official pipeline page (https://gitlab.com/cgps/ghru/pipelines/dsl2/pipelines/assembly). Good quality assemblies were considered when fastqc read quality was not “FAIL” in any of the evaluated parameters, bactinspector showed species name as expected for the isolate, no contamination was reported form Confindr, and assembly quality had less than 150 contigs per assembly with an N50 above 50000 bp.

Prediction of AMR was performed in the second pipeline that uses ARIBA [31] against ResFinder 4.0. [32], PlasmidFinder v2.1 [33], and VFDB [34] respectively (https://gitlab.com/cgps/ghru/pipelines/dsl2/pipelines/amr_prediction). For MSLT prediction MLST ARIBA software was used along with PubMLST databases [35]. All the software used in this automatic pipeline were run with default parameters, their databases were in Docker containers and updated to January 2022. In silico serovar prediction, was performed by SISTR v1.1.1 [36] and SeqSero2 v1.2.1. [37] packages with default parameters.

Additional core genome phylogenetic analysis was conducted using EnteroBase [38] on August 11th, 2023. Short-read sequences were assembled using the EnteroBase ToolKit (EtoKi) [38]. The genomic relatedness of the study strains to publicly available isolates on Enterobase was visualized with a GrapeTree plot with filters on the core genome multilocus sequence types (cgMLST) [39]. Swine isolates of serovars Typhimurium and 1, 4,[3],12:i:- from this study were compared to isolates of these serovars collected in Colombia (any source) and to isolates collected from swine (any location).

Virulence factor identification

For this analysis, the virulence factor database was used (VFDB; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8728188/). For the final analysis serovar Typhimurium isolate LT2 was used as a reference, as serovar Altona (n = 3) is not present on this database, and serovar I 1,4, [3],12:i:- (n = 20) should match closely with Typhimurium (n = 11). Two isolates (1802 and 1803) were removed from the VF analysis as they had poor quality sequencing metrics.

To compare the genomes to this database, SPADES was used to assemble the shot reads. Then BLAST compared these sequences to the VFDB database, where the query coverage was set to 75% and the percent nucleotide identity was set to 80%.

Results

Origin and Identification of strains and serotypes

A total of 653 swine samples were collected between 2019 and 2021 from farms across various municipalities in Antioquia, with 22.8% (149/653) testing positive for Salmonella. From the positive samples (n = 149), we selected 28 representative isolates based on antimicrobial resistance profiles observed during phenotypic evaluation while the samples were processed in our diagnostic facility. The goal of this study was to assess the utility of genomics analysis for investigating Salmonella from swine. Of the 28 samples, 8 were gut tissue, 15 were fecal samples, and 5 were rectal swabs. The distribution of these isolates across towns was as follows: Don Matías (n = 7), Amalfi (n = 3), Angelópolis (n = 4), Caldas (n = 2), Entrerríos (n = 1), Medellín (n = 1), San Pedro de los Milagros (n = 1), Santa Rosa de Osos (n = 6), Santo Domingo (n = 1), Támesis (n = 1), and Valparaíso (n = 1) (see Fig 1). Whole genome sequencing analysis identified three serotypes: Typhimurium (n = 10, 36%), Altona (n = 3, 11%), and I 4,[3],12:i:- (n = 15, 53%).

Fig 1. The geographical map depicts the location of Salmonella isolates in the different municipalities of Antioquia, Colombia.

Fig 1

The base map shapefile used in Qgis 3.34 was sourced from the publicly database Colombia en Mapas (https://www.colombiaenmapas.gov.co/).

Comparison with global serovar Typhimurium isolates

GrapeTree plots were used to visualize whether the serovar Typhimurium isolates from this study are related to 2265 serovar Typhimurium isolates also from swine that are publicly available (S1 Fig). Of the 11 serovar Typhimurium isolates from this study, two lineages were identified. The major lineage included ten isolates tightly clustered with one another and a median pairwise allelic difference (PAD) of 65 from the nearest common isolate. The other lineage included the remaining single serovar Typhimurium isolate (isolate 4351) and had a PAD of 19 from the nearest common isolates from Chile, Ecuador, and the United States. We next looked at serovar Typhimurium isolates from Colombia that were available on Enterobase and compared these to our swine isolates (Fig 2). A total of 88.6% (164/189) were from humans, and only a few non-human isolates were present in this analysis, including poultry (n = 5), rodent (n = 2), plant (n = 2), shellfish (n = 1), and unspecified meat (n = 1). Notably, none were from swine except for the isolates in the current study. All 11 isolates were clustered tightly with human isolates (PAD of < 15), especially isolate 4351, which clustered within a PAD of < 5, indicating a high relatedness to these isolates.

Fig 2. Serovar Typhimurium isolates from Colombia are most similar to human isolates.

Fig 2

All Salmonella serovar Typhimurium isolates from Colombia in the Enterobase database are shown on a GrapeTree plot using cgMLST profiles to show phylogenetic distance. White circles highlighted in red are isolates from this study. (Scale bar) Number of cgMLST pairwise allelic differences (PADs). “Missing” on the figure legend indicates the source type was not included in the metadata for included samples.

Comparison of serovar I 4, [3],12: I; - isolates from swine

A total of 2443 swine isolates matching to I,4, [3],12: I; - were plotted on a GrapeTree plot for visualizing phylogenetic analysis (Fig 3). Isolates from this study formed two distinct lineages, where 18 isolates clustered together nearest to seven isolates from Ecuador (PAD of 5). The remaining two isolates that formed the second, more minor lineage, was within a PAD of 10 from each other and five swine isolates from Brazil.

Fig 3. Serovar I, 4,[5], 12:i:-isolates from swine are closely related to isolates from Ecuador and Brazil.

Fig 3

All Salmonella serovar I, 4,[5], 12:i:- isolates from swine in the Enterobase database are shown on a GrapeTree plot using cgMLST profiles to show phylogenetic distance. White circles highlighted in red are isolates from this study. (Scale bar) Number of cgMLST pairwise allelic differences (PADs). “Missing” on the figure legend indicates the country of sample origin was not included in the metadata for included samples.

Comparison of serovar I 4, [3],12: I; - isolates from Colombia

Enterobase contains 32 isolates of serovar I 4, [3],12: I; - isolated from Colombia, and 20 isolates identified in this study. These 52 isolates had phylogenetic relationships visualized by a Grape Tree plot, showing core genome MLST identities (Fig 4). This GrapeTree plot resulted in two lineages of isolates from this study, where 18 clustered within 15 PADs of one another and other human isolates. The remaining two isolates (1638 and 4843) comprised the second, more minor lineage with PADs of less than four from two different human isolates. Notably, all isolates of serovar I 4,[3],12:I;- collected from Colombia outside this project have been from humans.

Fig 4. Serovar I, 4[5], 12:i:- isolates from Colombia show divergence of two clusters.

Fig 4

All Salmonella serovar 1, 4[5], 12:i:- isolates from Colombia in the Enterobase database are shown on a GrapeTree plot using cgMLST profiles to show phylogenetic distance. White circles highlighted in red are isolates from this study. (Scale bar) Number of cgMLST pairwise allelic differences (PADs). “Missing” on the figure legend indicates the source type was not included in the metadata for included samples.

Phenotypic characterization of antimicrobial resistance

All 28 isolates were resistant to at least one antimicrobial (Table 1), and 15 different resistance patterns were found in the 28 isolates. Of these, 26 (93%) had an MDR profile. The most frequently observed MDR profile was AMP-CEX-CEP-CEF-EFT-CEQ-FLU-ENR-TE-FFC-SXT, present in five (18%) serotype Typhimurium isolates. This profile includes six different classes of antibiotics. For serotype I 4, [3],12: i: - the most frequent pattern observed was FLU-TE-FFN (n = 4, 14%), and in the serotype Altona the pattern with the highest number of resistant antibiotics was NEO-FLU-ENR-MAR-TE-FFC (n = 1,3,6%).

Identification of antimicrobial resistance genes

The complete sequencing of the 28 Salmonella isolates revealed a great diversity of AMR genes, as seen in Table 2. In 25 isolates (89%), more than two resistance genes were found. Whereas in only three isolates (11%), only one resistance gene was present. In total, genes encoding resistance were found for ten different groups of antibiotics (beta-lactams, aminoglycosides, chloramphenicol, rifampicin, lincosamidas, fluoroquinolones, tetracyclines, sulfonamides, and trimethoprim) which will be described below.

Table 2. AMR genes combinations and phenotypic resistance patterns in Salmonella serovars recovered from swine production in Antioquia, Colombia.

Salmonella strain Serovar AMR gene profiles Phenotypic resistance patterns
1507 Typhimurium aac(6’)lb-cr, aph(3’)-lb, aph(6)-ld, aadA, bla CTX-M, bla OXA-1, bla TEM, catA 1, catB 3, dfrA14, floR, sul2, qnRb, tet (A) AMP, CEX, CEP, CEF, CFPZ, ENR,TE, FFC, STX, FLU
1804 Typhimurium aac(6’)lb-cr, aph(6)-ld, bla OXA-1, bla TEM, catA 1, dfrA14, tet (A),sul2 AMP, TE, SXT
1805 Typhimurium aac(6’) lb-cr,aadA1,aph(3’)-lb, aph(6)-ld, bla OXA-1, bla TEM, catA 1, catB 3, dfrA14, sul2, tet (A) AMP, CEF, TE, SXT
1806 Typhimurium aac (6’) lb-cr, aadA1, aph(3’)-lb, aph(6)-ld,bla OXA-1, bla TEM, catA 1, catB 3, dfrA14, sul2, tet (A) AMP, TE, SXT
1808 Altona qnRb TE, SXT, FLU
2502 I,4, [3],12: i: - aadA1, aadA2, aph(3’)-lb, cmlA, dfrA12, floR, sul3, tet (A) AMP, ENR, TE, SXT, FLU
3108 I, 4, [3],12: i: - aac(3)-ll, aadA2, aph(3’)-lla, aph(3’)-la, bla TEM, cmlA, dfrA12, floR, Inu(F) AMP, GEN, NEO, TE, FFC, SXT, FLU
3469 I, 4, [3],12: i: - floR,qnRb, tet (A) TE,FFC, FLU
3977 Typhimurium aac(6’)lb-cr, aadA, aadA13, aph(3’)-lb, aph(6)-ld, bla CTX-M, bla OXA-1, bla TEM, catA 1, catB 3, dfrA14, floR, sul2, tet (A) CEP, CFPZ, CEF, TE, FFC, SXT, FLU
4320 I, 4, [3],12: i: - aph(3’)-lb, floR, qnRb, tet (A) TE, FFC, FLU
4351 Typhimurium aph(3’)-lb, aph(6)-ld, sul2, tet (A) TE
4416 I, 4, [3],12: i: - floR,qnRb, tet (A) TE, FFC, FLU
4452 I, 4, [3],12: i: - aadA1, aadA13, arr, bla OXA-10, cmlA, dfrA14, floR, qnRb, tet (A) AMP, ENR, MAR, TE, FFC, FLU
4594 Typhimurium aac(6’)lb-cr, aadA, aadA13, aph(3’)-lb, aph(6)-ld, bla CTX-M, bla OXA-1, bla TEM, catA 1, catB 3, dfrA14, floR, sul2, tet (A) AMP, CEX, CEP, CFPZ, CEF, CFQ, ENR, TE, FFC, SXT, FLU
4843 I, 4, [3],12: i: - aac(3)-ll, aadA2, aph(3’)-lla, aph(3’)-la, bla TEM, dfrA12, floR, tet (B) AMP, ENR, MAR, TE, FFC
5226 I, 4, [3],12: i: - aadA2, dfrA12, floR, qnRb, tet (a) TE, FFC, SXT, FLU
5672 I, 4, [3],12: i: - aadA13, aadA1, arr, bla OXA-10, cmlA, dfrA14, floR, qnRb, tet (A) AMP, ENR, TE, FFC, FLU
5678 I, 4, [3],12: i: - aadA13, aadA1, bla OXA-10, cmlA, dfrA14, floR, qnRb, tet (A) AMP, ENR, TE, FFC, FLU
5781 I, 4, [3],12: i: - aadA1, aadA2, bla TEM, cmlA, floR, qnRb, sul3, tet (A) AMP, CEF, TE, FFC, FLU
5782 I, 4, [3],12: i: - aadA1, aadA2, bla TEM, cmlA, floR, qnRb, sul·, tet (A) AMP, CEF, TE, FFC, FLU
5785 I, 4, [3],12: i: - aadA13, aadA1, aadA2, bla TEM, cmlA, floR, qnRb, sul3, tet (A) AMP, CEF, TE, FFC, FLU
6113 Altona qnRb FLU, TE, FLU
6114 I, 4, [3],12: i: - qnRb FLU, ENR, TE, FFC, NEO, FLU
6245 I, 4, [3],12: i: - aadA1, aadA2, aph(3’)-la, floR, qnRb, tet (A) NEO, ENR, MAR, TE, FFC, FLU
6246 Altona aadA2, aph(3’)-la, floR, qnRb, tet (A) NEO, ENR, MAR, TE, FFC, FLU
6322 Typhimurium aadA13, aph(3’)-lb, aph(6)-ld, bla TEM, catA 1, dfrA14, floR, qnRb, sul2, tet (A) AMP, CEX, CEP, CEF, CFPZ, ENR,TE, FFC, STX, FLU
6323 Typhimurium aadA13, aadA1, aph(3’)-lb, aph(6)-ld, bla TEM, catA1, dfrA14, floR, qnRb, sul2, tet (A) AMP, CEX, CEP, CEF, CFPZ, ENR,TE, FFC, STX, FLU
6667 Typhimurium aac(3)-ll, aac(6’)lb-cr, aadA13, aadA1, aph(3’)-lb, aph(6)-ld, bla CTX-M, bla OXA, bla TEM, catA1, catB 3, dfrA14, qnRb, tet (A) AMP, CEX, CEP, CEF, CFPZ, ENR,TE, FFC, STX, FLU

AMP: ampicillin, CEX: cefalexin, CEP: cephalothin, CFPZ: cefoperazone, CEF: ceftiofur, CFQ: cefquinome, GEN: gentamicin, FLU: flumequine, ENR: enrofloxacine, TE: tetracycline, FFC: florfenicol, SXT: trimethoprim-sulfamethoxazole, MAR: marbofloxacine, NEO: neomicyn.

Genotypic resistance to beta-lactams

Genes encoding resistance to extended-spectrum betalactamases (ESBL) were found in 17 (61%) isolates. blaTEM was the most common gene (n = 14, 50%), followed by the blaOXA-1 genes (n = 6, 21%), blaOXA-10 (n=3, 10%), blaOXA (n = 1, 3,5%) and blaCTX-M (n = 4, 14%). A total of 8 isolates presented combinations of the genes bla TEM, blaOXA-1, and blaCTX-M (Table 2).

Genotypic resistance to aminoglycosides

The most remarkable diversity of AMR genes was found for those encoding resistance to aminoglycosides. The gene aac(3) was detected in a single isolate (3.5% in the same way as its variations aac(3)-II (n = 1, 3.5%) and aac(3)-Iid (n = 1, 3.5%) and in a total of 7 isolates (25%) the gene aac(6’)lb-cr was evidenced. The following genetic cases were observed: aadA (n = 2.7%), aadA1 (n = 17, 61%), aadA13 (n = 8, 28%), aadA2 (n = 6, 21%), aadA 12 (n =1, 3.5%). The aph(3’)-lb gene was found in 11 isolates (39%), followed by the aph(3’)-la (n = 5, 18%) and aph(3’)-lla (n = 1, 3.5%) genes. Additionally, the aph(6)-ld gene (n = 11, 39%) was also detected (Table 2).

Genotypic resistance to chloramphenicol, rifampicines, lincosamides, and fluoroquinolones

The floR gene (n = 21, 75%) was widely found among the isolates. Other genes that confer resistance to chloramphenicol were also detected: catA1 (n = 9, 32%), catB3 (n = 7, 25, and cmlA (n = 7, 25%). Regarding resistance to rifampicin, the arr gene was found (n = 4, 14%). In the Resistance to incosamidas, the cassette gene InuF was evidenced in only one isolate (3.5%). On the other hand, associated with resistance to fluoroquinolones, the qnRb gene was found in most isolates (n = 22, 78%) (Table 2).

Genotypic resistance to tetracyclines, sulfonamides and trimethoprim

The tetA gene that confers resistance to tetracyclines was the most found among the isolates (n = 24, 86%). The presence of the tetB (n = 1, 3.5%) and tetM (n=1, 3.5%) genes was less prevalent. For sulfonamide resistance, the sul2 (n = 12, 43%), sul3 (n = 5, 18%) and sul1 (n = 1, 3.5%) genes were present. Additionally, two genes that confer resistance to trimethoprim were detected: dfrA14 (n = 12, 43%) and dfrA12 (n = 4, 14%) (Table 2).

Virulence genes

In all serovar Altona isolates (n = 3), genes responsible for adherence and effector delivery systems, including the stcABCD, safABCD, and pefABCD operons were absent. Additional virulence factors that were absent only in Altona included: flgB (motility), STM3026 (adherence, std cluster), STM0290 (sciW; effector delivery), STM0283 (effector delivery/secretion), gogB (effector delivery), sseI/srfH (effector delivery), ratB (adherence), mig-5 (antimicrobial), sspH2 (effector delivery), sodCI (stress survival), and lpfD (adherence). Unsurprisingly, Typhimurium and I 4,[3],12:i:- isolates have very similar virulence factors. The main difference is the expected absence of fljA and fljB motility genes in I 4,[3],12:i:-. The sspH1 gene was absent from all 28 genomes.

Discussion

In Colombia, several studies have documented that the prevalence of Salmonella spp. In pig farms exceeds 25% [4043]. Antioquia, as the leading pig producer in the country, has experienced relatively low disease prevalence, primarily due to advancements in technology and enhanced biosecurity measures on swine farms [42]. However, it is important to note that there are currently no regulations or action plans for antimicrobial use in pig production, nor strategies for reducing antimicrobial use in Colombia.

Among the isolates evaluated, three serotypes were found: Typhimurium, I 4, [3],12:i:-, and Altona. Serotype Typhimurium is frequently found in pigs, slaughterhouses, and pork products [44] and is one of the most prevalent serovar worldwide [45]. It is responsible for 17.4% of human salmonellosis in the European Union, North America, and Oceania, but this differs in South America, where the Meleagridis serovar is the most reported in the region [4,46]. Salmonella I, 4, [3],12: i:-, a monophasic variant of serotype Typhimurium, is one of the five most commonly reported serovars in human diseases worldwide [47]. Additionally, this serovar is widely associated with swine production, especially in Europe and the United States, suggesting a potential link between human infections and consumption of contaminated pork products [48]. Salmonella Altona was the least found serotype. An outbreak in humans associated with this serotype was reported in the United States, affecting 68 people across 20 states in 2011 [49], where the risk from contact with live poultry was highlighted, especially for young children [50]. This is the first study to report the presence of serotype Altona in Colombia.

In this study, patterns like the ACSuGSTTm (ampicillin, chloramphenicol, sulfonamides, gentamicin, streptomycin, tetracycline, and trimethoprim) predominated among serotype I, 4, [3],12: i:-, isolates, representing 67% (10/15) of the cases. Globally, serotype I, 4, [3], 12: i:-, has displayed three prominent lineages, all associated with swine but exhibiting distinct antimicrobial resistance profiles. The “Spanish clone” presents the ACSuGSTTm phenotypic pattern [51], whereas the “USA clone” lacks an extensive MDR pattern but shows resistance to quinolones and extended-spectrum cephalosporins [52]. The “European clone” has been documented in multiple EU countries, characterized by a predominant ASSuT pattern (ampicillin, streptomycin, sulfonamides, and tetracycline) [53].

The highest rate of phenotypic resistance is recorded for tetracyclines (100%), which is one of the most widely used antimicrobials in pig feed in Colombia. In commercial pig operations, tetracyclines are used for therapeutic purposes to treat septicemia and intestinal and respiratory infections [54,55]. Resistance to tetracyclines is frequent in both commensal and pathogenic bacteria, primarily because of the acquisition of blatet genes [5658]. In this study, a high presence of the blatetA gene was found (86%), concordant with multiple investigations in swine conducted in China, where the gene was present in 64% and 95% of the isolates evaluated [59,60].

The production of beta-lactamases is considered the primary mechanism of resistance to beta-lactam antibiotics [61], especially in gram-negative pathogens [62]. The literature describes that Salmonella isolates harboring ESBL enzymes have emerged globally recently, with the blaCTX-M [63] group being critical. Despite this, the blaTEM gene was the most found in this study (50%), and the blaCTX-M gene was only evidenced in 14% of the isolates.

Prior investigations have documented that chloramphenicol resistance primarily arises through inactivation by chloramphenicol acetyltransferase (CAT), which is encoded by the catA1, catA2, and catB genes [64]. Although these genes were identified in our study, they did not exhibit high prevalence. Instead, our study reveals the prominence of the floR gene (75%) as the principal factor in conferring chloramphenicol resistance. This gene has been previously documented in serotype Typhimurium and its monophasic variant (I 4,[3],12:i:) [65], with the floR gene assuming a pivotal role within the cohort of multidrug resistance genes concomitant with SGI1 [66].

Despite their toxicity, and the residues in tissues, antibiotics such as aminoglycosides, have been used to treat undifferentiated diarrhea in weaned piglets and swine dysentery caused by Brachyspira hyodysenteriae [67]. In this study, the aph genes were identified in most isolates, underscoring a notable genetic diversity with a total of 6 distinct gene. Most aph(3’) enzymes are widespread among pathogenic microorganisms and, together with the enzyme aph(6) (also found in this study), are highly related to resistance to streptomycin [68]. Two recent studies conducted in Brazil revealed the presence of the aph(3’)-lb gene in samples of humans and contaminated food [69,70]. The aph(3’)-lb gene was the most commonly associated with aminoglycoside resistance in this study.

The qnRb gene, conferring resistance to the quinolones, was widely distributed among our isolates, and was found in all the three serotypes. In contrast, studies conducted in Thailand and China showed a low distribution of the gene among the isolates analyzed [71,72]. This gene imparts reduced resistance levels to quinolones [73], and resistance is directly related to the expression levels of gene [74]. On the other hand, resistance to trimethoprim is mediated by genes encoding dihydrofolate reductase variants (dhfr and dfr) that have decreased affinity for the antimicrobial agent [75]. The most found gene was dfrA14, previously reported in Salmonella isolates from raw chicken in Brazil, Chile, and Thailand [76].

In veterinary medicine, the development of antimicrobial resistance is closely related to the excessive use of antimicrobial agents, which facilitates microorganisms with newly acquired mutations or resistance genes to survive and proliferate [77]. Evidence shows that food from animal sources at all stages of food processing contain many resistant bacteria [78]. The concern focuses on the horizontal transmission of genes, being the main responsible for the transmission of AMR, which results in a rapid dissemination of AMR between bacteria and species [79]. Globally, a crisis unfolds as we repeatedly observe a gene in a specific organism, subsequently leading to global reports of the gene appearing in other organisms and locations [80].

Reduced and prudent use of antimicrobials in animal production could limit the selection of resistant bacteria and may lead to a reversal of susceptibility [81]. Countries such as Denmark have made significant progress in controlling AMR by implementing management programs in the veterinary sector as early as 1998. As a result, in Denmark, the amount of antimicrobials consumed per kilogram of produced pork fell by 50% between 1994 and 2013 [82]. In Colombia, there is a need for improved and controlled use of antibiotics and surveillance strategies to help reduce the high levels of AMR observed in production animals [83]. This study illustrates that the Salmonella isolates assessed in pigs harbor a diverse array of antimicrobial resistance genes. This is also a problem for veterinarians as the emergence of AMR and MDR can increase the spread of resistant pathogens within animal production systems causing treatment failures that can put animal health at risk [84]. The contribution of individual countries in reducing AMR will be essential to mitigate the global problem since antibiotic resistance spreads on a macroscopic scale. Antimicrobial resistance genes (ARGs) in plasmids can facilitate the spread from a resistant bacterium to a susceptible one, allowing the development of new resistant organisms. On the other hand, individual resistant organisms and colonies spread around the world as colonized or infected patients travel. The mode of spread is on the rise with the increasing globalization [85].

An earlier molecular characterization conducted in serovars Typhimurium and 1,4,[3],12:i:- found the sspH1 gene in 77% of isolates as a virulence determinant related to the prophage [86], a finding not observed in this study. Additionally, previous studies found an association between the presence of the sspH1 gene and phenotypic MDR [87]. However, this association was not identified in our study, as the presence of the sspH1 gene was not detected in any of the isolates.

The phylogenetic comparison of isolates from this study to other isolates from swine or Colombia was limited due to the low number of swine isolates from Colombia and elsewhere in South America compared to other countries, such as the United States, where whole genome sequencing is performed more routinely. The few publicly available isolates present were found to be genetically like to the isolates of this study, suggesting that strains of both serovars Typhimurium and I 4, [3],12: i: - could be commonly identified in this region. There was no concordance between AMR profiles in the more minor lineages containing only one or two isolates when compared to the remaining study strains of either serovar Typhimurium or I 4, [3],12: i: - but further analysis is required to determine the genomic differences between clades observed on the GrapeTree plots for both serovars. Due to a limited number of studies investigating the burden of Salmonella in Colombia [88], human isolates make up most data on Enterobase, which limits the information that can be obtained through the newly acquired WGS data presented here. Thus, doing regular surveillance of Salmonella from swine production in Colombia, increasing the number of comparable isolates and identifying strains related to human outbreaks, could increase the efficiency in detecting related isolates and in supporting targeted and improved Salmonella control for swine producers.

The limitation of resources in this study precluded the phenotypic and genome sequencing analysis of all Salmonella isolates. The authors believe that employing such technology would be of significant value for molecular epidemiology studies. These would enhance the understanding of the dynamics of antimicrobial resistance in Salmonella isolates in Antioquia, Colombia. Furthermore, complete genome sequencing could provide deeper insights into the genetic mechanisms driving resistance, facilitate the identification of novel resistance genes, and support the development of more targeted and effective control strategies. Addressing this limitation in future research could greatly contribute to a more nuanced understanding of resistance patterns and inform public health and policy interventions.

Conclusion

This study, conducted through whole-genome sequencing, not only identified the presence of multidrug-resistant Salmonella in pigs intended for human consumption in Antioquia, Colombia but also allowed for a comprehensive analysis of genetic diversity and precise identification of resistance genes. This advanced approach provided a more detailed and complete understanding of virulence and antimicrobial resistance factors, emphasizing the significance of whole-genome sequencing in comprehensively addressing the issue of resistance in pig production and its impact. Furthermore, the authors underscore the imperative for the formulation of public policies aimed at regulating antibiotic use within pig production systems in Colombia. They also advocate for the establishment of educational programs designed to enhance producer awareness regarding the rational use of antibiotics.

Supporting information

S1 Fig. Serovar Typhimurium isolates from swine form two distinct clusters.

All Salmonella serovar Typhimurium isolates from swine in the Enterobase database are shown on a GrapeTree plot using cgMLST profiles to show phylogenetic distance. White circles highlighted in red are isolates from this study. (Scale bar) Number of cgMLST pairwise allelic differences (PADs).”Missing” on the figure legend indicates the country of sample origin was not included in the metadata for included samples.

(TIF)

pntd.0012830.s001.tif (1.2MB, tif)

Data Availability

All WGS data supporting the findings of this study have been deposited in the National Center for Biotechnology Information (NCBI) Sequence Read Archive under BioProject ID PRJNA1168507.

Funding Statement

This study was supported by the Sustainability Strategy of the CIBAV Research Group, School of Veterinary Medicine, Faculty of Agricultural Sciences, University of Antioquia (UdeA), Medellín, Colombia (to JJCG), and by the Global Health Research Unit for the Genomic Surveillance of Antimicrobial Resistance-Colombia (to PDG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We also acknowledge the support of the Department of Population Health, Poultry Diagnostic and Research Center, University of Georgia.

References

  • 1.Wibisono FM, Wibisono FJ, Effendi MH, Plumeriastuti H, Hidayatullah AR, Hartadi EB, et al. A review of salmonellosis on poultry farms: Public health importance. Syst Rev Pharm. 2020;11(9):481–6. [Google Scholar]
  • 2.Andino A, Hanning I. Salmonella enterica: survival, colonization, and virulence differences among serovars. Sci World J. 2015;2015:520179. doi: 10.1155/2015/520179 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Consumo per cápita de carne de cerdo en Colombia. Porkcolombia. 2022. [Google Scholar]
  • 4.Ferrari RG, Rosario DKA, Cunha-Neto A, Mano SB, Figueiredo EES, Conte-Junior CA, et al. Worldwide Epidemiology of Salmonella Serovars in Animal-Based Foods: a Meta-analysis. Appl Environ Microbiol. 2019;85(14):e00591–19. doi: 10.1128/AEM.00591-19 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Instituto Colombiano Agropecuario. Censos pecuarios nacional. 2023.
  • 6.Ministerio de Agricultura y Desarrollo Rural. Cadena Cárnica porcina. 2021.
  • 7.Comunicado de prensa: Consumo de carne de cerdo en Colombia llegó a 13 kg por persona en 2022. Porkcolombia. 2023. [Google Scholar]
  • 8.El valor de la actividad porcícola. Porkcolombia. 2022. [Google Scholar]
  • 9.Shang K, Wei B, Cha S-Y, Zhang J-F, Park J-Y, Lee Y-J, et al. The Occurrence of Antimicrobial-Resistant Salmonellaenterica in Hatcheries and Dissemination in an Integrated Broiler Chicken Operation in Korea. Animals (Basel). 2021;11(1):154. doi: 10.3390/ani11010154 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Brown A, Grass J, Richardson L, Nisler A, Bicknese A, Gould L, et al. Antimicrobial resistance in salmonella that caused foodborne disease outbreaks: United States, 2003–2012. Epidemiol Infect. 2017;145:766–74. doi: 10.1017/S0950268816002867 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.VanderWaal K, Deen J. Global trends in infectious diseases of swine. Proc Natl Acad Sci U S A. 2018;115(45):11495–500. doi: 10.1073/pnas.1806068115 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Van TTH, Yidana Z, Smooker P, Coloe P. Antibiotic use in food animals in the world with focus on Africa: pluses and minuses. J Glob Antimicrob Resist. 2019. doi: 10.1016/j.jgar.2019.07.031 [DOI] [PubMed] [Google Scholar]
  • 13.Chokshi A, Sifri Z, Cennimo D, Horng H. Global contributors to antibiotic resistance. J Glob Infect Dis. 2019;11(1):36–42. doi: 10.4103/jgid.jgid_110_18 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Vidal J, Clavijo V, Castellanos L, Kathiresan J, Kumar A, Mehta K, et al. Multidrug-resistant Salmonella spp. in fecal samples of pigs with suspected salmonellosis in Antioquia, Colombia, 2019–2021. Rev Panam Salud Publica. 2023;47:2023. doi: 10.26633/RPSP.2023.46 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Giraldo-Cardona J, Gualdrón-Ramírez D, Chamorro-Tobar I, Pulido-Villamarín A, Santamaría-Durán N, Castañeda-Salazar R, et al. Salmonella spp. prevalence, antimicrobial resistance and risk factor determination in Colombian swine farms. Pesquisa Veterinária Brasileira. 2019;39:816–22. [Google Scholar]
  • 16.Abraham S, O’Dea M, Page SW, Trott DJ. Current and future antimicrobial resistance issues for the Australian pig industry. Anim Prod Sci. 2017;57(12):2398. doi: 10.1071/an17358 [DOI] [Google Scholar]
  • 17.Moreno-Switt A, Pezoa D, Sepúlveda V, González I, Rivera D, Retamal P, et al. Transduction as a potential dissemination mechanism of a clonal qnrB19-carrying plasmid isolated from Salmonella of multiple serotypes and isolation sources.. Fron Microbiol. 2019;10:2503. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.MANUAL DE. OIE sobre animales terrestres. 2004. Brucelosis (en línea) Consult. 12. [Google Scholar]
  • 19.Díaz CA, Est MNR, MV VJV, Ramírez G, Casas GA, Mogollón JD, et al. Revista Colombiana de Ciencias Pecuarias. Revista Colombiana de Ciencias Pecuarias. 2011;24(2):131–44. [Google Scholar]
  • 20.Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing. 31st Edition. Published 2021. cited 2021 July 22. [Google Scholar]
  • 21.Wingett SW, Andrews S. FastQ Screen: A tool for multi-genome mapping and quality control. F1000Res. 2018;7:1338. doi: 10.12688/f1000research.15931.2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Underwood A. BactInspector. Available from: https://gitlab.com/antunderwood/bactinspector. [Google Scholar]
  • 23.Low AJ, Koziol AG, Manninger PA, Blais B, Carrillo CD. ConFindr: rapid detection of intraspecies and cross-species contamination in bacterial whole-genome sequence data. PeerJ. 2019;7:e6995. doi: 10.7717/peerj.6995 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Bolger AM, Lohse M, Usadel B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics. 2014;30(15):2114–20. doi: 10.1093/bioinformatics/btu170 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Ondov B, Treangen T, Melsted P, Mallonee A, Bergman N, Koren S, et al. Mash: fast genome and metagenome distance estimation using MinHash. Geno Biol. 2016;17(132). doi: 10.1186/s13059-016-0997-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Li H. Seqtk;. Available from: https://github.com/lh3/seqtk. [Google Scholar]
  • 27.Magoč T, Salzberg SL. FLASH: fast length adjustment of short reads to improve genome assemblies. Bioinformatics. 2011;27(21):2957–63. doi: 10.1093/bioinformatics/btr507 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Song L, Florea L, Langmead B. Lighter: fast and memory-efficient sequencing error correction without counting. Geno Biol. 2014;15(509). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Bankevich A, Nurk S, Antipov D, Gurevich AA, Dvorkin M, Kulikov AS, et al. SPAdes: a new genome assembly algorithm and its applications to single-cell sequencing. J Comput Biol. 2012;19(5):455–77. doi: 10.1089/cmb.2012.0021 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Gurevich A, Saveliev V, Vyahhi N, Tesler G. QUAST: quality assessment tool for genome assemblies. Bioinformatics. 2013;29(8):1072–5. doi: 10.1093/bioinformatics/btt086 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Hunt M, Mather AE, Sánchez-Busó L, Page AJ, Parkhill J, Keane JA, et al. ARIBA: rapid antimicrobial resistance genotyping directly from sequencing reads. Microb Genom. 2017;3(10):e000131. doi: 10.1099/mgen.0.000131 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Zankari E, Hasman H, Cosentino S, Vestergaard M, Rasmussen S, Lund O, et al. Identification of acquired antimicrobial resistance genes. J Antimicrob Chemother. 2012;67(11):2640–4. doi: 10.1093/jac/dks261 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Carattoli A, Zankari E, García-Fernández A, Voldby Larsen M, Lund O, Villa L, et al. In silico detection and typing of plasmids using PlasmidFinder and plasmid multilocus sequence typing. Antimicrob Agents Chemother. 2014;58(7):3895–903. doi: 10.1128/AAC.02412-14 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Chen L, Zheng D, Liu B, Yang J, Jin Q. VFDB 2016: hierarchical and refined dataset for big data analysis--10 years on. Nucleic Acids Res. 2016;44(D1):D694-7. doi: 10.1093/nar/gkv1239 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Jolley KA, Bray JE, Maiden MCJ. Open-access bacterial population genomics: BIGSdb software, the PubMLST.org website and their applications. Wellcome Open Res. 2018. Sep 24;3:124. doi: 10.12688/wellcomeopenres.14826.1 PMID: 30345391 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Yoshida CE, Kruczkiewicz P, Laing CR, Lingohr EJ, Gannon VPJ, Nash JHE, et al. The salmonella in silico typing resource (SISTR): an open web-accessible tool for rapidly typing and subtyping draft salmonella genome assemblies. PLoS One. 2016;11(1):e0147101. doi: 10.1371/journal.pone.0147101 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Zhang S, den Bakker HC, Li S, Chen J, Dinsmore BA, Lane C, et al. SeqSero2: rapid and improved salmonella serotype determination using whole-genome sequencing data. Appl Environ Microbiol. 2019;85(23):e01746-19. doi: 10.1128/AEM.01746-19 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Zhou Z, Alikhan N-F, Mohamed K, Fan Y, Achtman M. The EnteroBase user’s guide, with case studies on Salmonella transmissions, Yersinia pestis phylogeny, and Escherichia core genomic diversity. Genome Res. 2019;30(1):138–52. doi: 10.1101/gr.251678.119 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Price MN, Dehal PS, Arkin AP. FastTree 2--approximately maximum-likelihood trees for large alignments. PLoS One. 2010;5(3):e9490. doi: 10.1371/journal.pone.0009490 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Zhou Z, Alikhan N-F, Sergeant MJ, Luhmann N, Vaz C, Francisco AP, et al. GrapeTree: visualization of core genomic relationships among 100,000 bacterial pathogens. Genome Res. 2018;28(9):1395–404. doi: 10.1101/gr.232397.117 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Zeng Y-B, Xiong L-G, Tan M-F, Li H-Q, Yan H, Zhang L, et al. Prevalence and antimicrobial resistance of salmonella in pork, chicken, and duck from retail markets of China. Foodborne Pathog Dis. 2019;16(5):339–45. doi: 10.1089/fpd.2018.2510 [DOI] [PubMed] [Google Scholar]
  • 42.Ávila E, Cardona L, Fandiño L, Barragán I. Prevalencia de Salmonella spp. en carne porcina, plantas de beneficio y expendios del Tolima. Orinoquia. 2013;17(1):59–68. [Google Scholar]
  • 43.Ayala-Romero C, Ballen-Parada C, Rico-Gaitan M, Chamorro-Tobar I, Zambrano-Moreno D, Poutou-Piñales R, et al. Prevalencia de Salmonella spp., en ganglios mesentéricos de porcinos en plantas de beneficio Colombianas. Rev MVZ Córdoba. 2018;23(1):6447–86. doi: 10.21897/rmvz.1242 [DOI] [Google Scholar]
  • 44.Giraldo-Cardona JP, Gualdrón-Ramírez D, Chamorro-Tobar I, Pulido-Villamarín A, Santamaría-Durán N, Castañeda-Salazar R, et al. Salmonella spp. prevalence, antimicrobial resistance and risk factor determination in Colombian swine farms. Pesq Vet Bras. 2019;39(10):816–22. doi: 10.1590/1678-5150-pvb-6156 [DOI] [Google Scholar]
  • 45.Campos J, Mourão J, Peixe L, Antunes P. Non-typhoidal Salmonella in the Pig Production Chain: A Comprehensive Analysis of Its Impact on Human Health. Pathogens. 2019;8(1):19. doi: 10.3390/pathogens8010019 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46. Zhou Z, Jin X, Zheng H, Li J, Meng C, Yin K, et al. The prevalence and load of Salmonella, and key risk points of Salmonella contamination in a swine slaughterhouse in Jiangsu province, China. Food Control. 2018;87:153–60. doi: 10.1016/j.foodcont.2017.12.026 [DOI] [Google Scholar]
  • 47.Bearson SMD. Salmonella in Swine: Prevalence, Multidrug Resistance, and Vaccination Strategies. Annu Rev Anim Biosci. 2022;10:373–93. doi: 10.1146/annurev-animal-013120-043304 [DOI] [PubMed] [Google Scholar]
  • 48.Sun H, Wan Y, Du P, Bai L. The Epidemiology of Monophasic Salmonella Typhimurium. Foodborne Pathog Dis. 2019. doi: 10.1089/fpd.2019.2676 [DOI] [PubMed] [Google Scholar]
  • 49.Multistate CDC. Outbreak of human Salmonella Altona and Salmonella johannesburg infections linked to chicks and ducklings (final update). CDC. 2011. [PubMed] [Google Scholar]
  • 50.Hirai N, Kasahara K, Yoshihara S, Nishimura T, Ogawa Y, Ogawa T. Spinal epidural abscess caused by non-typhoidal Salmonella: a case report and literature review. J Infect Chemother. 2020. doi: 10.1016/j.jiac.2020.05.016 [DOI] [PubMed] [Google Scholar]
  • 51.Qin X, Yang M, Cai H, Liu Y, Gorris L, Aslam MZ, et al. Antibiotic resistance of salmonella typhimurium monophasic variant 1,4,[5],12:i:-in China: a systematic review and meta-analysis. Antibiotics (Basel). 2022;11(4):532. doi: 10.3390/antibiotics11040532 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Elnekave E, Hong S, Taylor A, Boxrud D, Rovira A, Alvarez J. Tracing the evolutionary history of an emerging Salmonella 4,[5],12:i:- clone in the United States.. Virus Evolution. 2019;5:19–20. [Google Scholar]
  • 53.Yang X, Wu Q, Zhang J, Huang J, Chen L, Wu S, et al. Prevalence, bacterial load, and antimicrobial resistance of salmonella serovars isolated from retail meat and meat products in China. Front Microbiol. 2019;10:2121. doi: 10.3389/fmicb.2019.02121 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Possebon F, Tiba Casas M, Nero L, Yamatogi R, Araújo Jr. J, Pinto J de A. Prevalence, antibiotic resistance, PFGE and MLST characterization of Salmonella in swine mesenteric lymph nodes. Prev Vet Med. 2020;179:105024. doi: 10.1016/j.prevetmed.2020.105024 [DOI] [PubMed] [Google Scholar]
  • 55.Wang R, Chen M, Feng F, Zhang J, Sui Q, Tong J, et al. Effects of chlortetracycline and copper on tetracyclines and copper resistance genes and microbial community during swine manure anaerobic digestion. Bioresour Technol. 2017;238:57–69. doi: 10.1016/j.biortech.2017.03.134 [DOI] [PubMed] [Google Scholar]
  • 56.Ricker N, Trachsel J, Colgan P, Jones J, Choi J, Lee J, et al. Toward antibiotic stewardship: route of antibiotic administration impacts the microbiota and resistance gene diversity in swine feces. Front Vet Sci. 2020;7:255. doi: 10.3389/fvets.2020.00255 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Debroy R, Miryala SK, Naha A, Anbarasu A, Ramaiah S. Gene interaction network studies to decipher the multi-drug resistance mechanism in Salmonella enterica serovar Typhi CT18 reveal potential drug targets. Microb Pathog. 2020;142:104096. doi: 10.1016/j.micpath.2020.104096 [DOI] [PubMed] [Google Scholar]
  • 58.Li Q, Yin J, Li Z, Li Z, Du Y, Guo W, et al. Serotype distribution, antimicrobial susceptibility, antimicrobial resistance genes and virulence genes of Salmonella isolated from a pig slaughterhouse in Yangzhou, China. AMB Express. 2019;9(1):210. doi: 10.1186/s13568-019-0936-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Wang W, Chen J, Shao X, Huang P, Zha J, Ye Y. Occurrence and antimicrobial resistance of Salmonella isolated from retail meats in Anhui, China. Food Sci Nutr. 2021;9(9):4701–10. doi: 10.1002/fsn3.2266 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Liu Q, Chen W, Elbediwi M, Pan H, Wang L, Zhou C, et al. characterization of salmonella resistome and plasmidome in pork production system in Jiangsu, China. Front Vet Sci. 2020;7:617. doi: 10.3389/fvets.2020.00617 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Adel WA, Ahmed AM, Hegazy Y, Torky HA, Shimamoto T. High prevalence of ESBL and plasmid-mediated quinolone resistance genes in salmonella enterica isolated from retail meats and slaughterhouses in Egypt. Antibiotics (Basel). 2021;10(7):881. doi: 10.3390/antibiotics10070881 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Pitout JDD, Laupland KB. Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis. 2008;8(3):159–66. doi: 10.1016/S1473-3099(08)70041-0 [DOI] [PubMed] [Google Scholar]
  • 63.Riaño I, Moreno MA, Teshager T, Sáenz Y, Domínguez L, Torres C. Detection and characterization of extended-spectrum beta-lactamases in Salmonella enterica strains of healthy food animals in Spain. J Antimicrob Chemother. 2006;58(4):844–7. doi: 10.1093/jac/dkl337 [DOI] [PubMed] [Google Scholar]
  • 64.Mąka Ł, Popowska M. Antimicrobial resistance of Salmonella spp. isolated from food. Rocz Panstw Zakl Hig. 2016;67(4):343–58. [PubMed] [Google Scholar]
  • 65.Fernandes L, Centeno MM, Couto N, Nunes T, Almeida V, Alban L, et al. Longitudinal characterization of monophasic Salmonella Typhimurium throughout the pig’s life cycle. Vet Microbiol. 2016;192:231–7. doi: 10.1016/j.vetmic.2016.07.018 [DOI] [PubMed] [Google Scholar]
  • 66.Michael GB, Butaye P, Cloeckaert A, Schwarz S. Genes and mutations conferring antimicrobial resistance in Salmonella: an update. Microbes Infect. 2006;8(7):1898–914. doi: 10.1016/j.micinf.2005.12.019 [DOI] [PubMed] [Google Scholar]
  • 67.Frye JG, Jackson CR. Genetic mechanisms of antimicrobial resistance identified in Salmonella enterica, Escherichia coli, and Enteroccocus spp. isolated from U.S. food animals. Front Microbiol. 2013;4:135. doi: 10.3389/fmicb.2013.00135 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Serio AW, Magalhães ML, Blanchard JS, Connolly LE. Aminoglycosides: mechanisms of action and resistance. Antimicrobial Drug Resistance. 2017;213–29. doi: 10.1007/978-3-319-46718-4_14 [DOI] [Google Scholar]
  • 69.de Melo ANF, Monte DFM, de Souza Pedrosa GT, Balkey M, Jin Q, Brown E, et al. Genomic investigation of antimicrobial resistance determinants and virulence factors in Salmonella enterica serovars isolated from contaminated food and human stool samples in Brazil. Int J Food Microbiol. 2021;343:109091. doi: 10.1016/j.ijfoodmicro.2021.109091 [DOI] [PubMed] [Google Scholar]
  • 70.Cao G, Balkey M, Jin Q, Brown E, Allard M, de Melo ANF, et al. Genomic and phylogenetic analysis of Salmonella enterica serovar Enteritidis strains linked to multiple outbreaks in Brazil. Lett Appl Microbiol. 2023;76(1):ovac045. doi: 10.1093/lambio/ovac045 [DOI] [PubMed] [Google Scholar]
  • 71.Sinwat N, Angkittitrakul S, Coulson KF, Pilapil FMIR, Meunsene D, Chuanchuen R. High prevalence and molecular characteristics of multidrug-resistant Salmonella in pigs, pork and humans in Thailand and Laos provinces. J Med Microbiol. 2016;65(10):1182–93. doi: 10.1099/jmm.0.000339 [DOI] [PubMed] [Google Scholar]
  • 72.He J, Sun F, Sun D, Wang Z, Jin S, Pan Z, et al. Multidrug resistance and prevalence of quinolone resistance genes of Salmonella enterica serotypes 4,[5],12:i:- in China. Int J Food Microbiol. 2020;330:108692. doi: 10.1016/j.ijfoodmicro.2020.108692 [DOI] [PubMed] [Google Scholar]
  • 73.Jacoby GA, Walsh KE, Mills DM, Walker VJ, Oh H, Robicsek A, et al. qnrB, another plasmid-mediated gene for quinolone resistance. Antimicrob Agents Chemother. 2006;50(4):1178–82. doi: 10.1128/AAC.50.4.1178-1182.2006 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74.Ruiz J. Transferable mechanisms of quinolone resistance from 1998 onward. Clin Microbiol Rev. 2019;32(4): e00007–19. doi: 10.1128/CMR.00007-19 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75.Davies N, Jørgensen F, Willis C, McLauchlin J, Chattaway MA. Whole genome sequencing reveals antimicrobial resistance determinants (AMR genes) of Salmonella enterica recovered from raw chicken and ready-to-eat leaves imported into England between 2014 and 2019. J Appl Microbiol. 2022;133(4):2569–82. doi: 10.1111/jam.15728 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76.Hughes D, Andersson DI. Environmental and genetic modulation of the phenotypic expression of antibiotic resistance. FEMS Microbiol Rev. 2017;41(3):374–91. doi: 10.1093/femsre/fux004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 77.Ma F, Xu S, Tang Z, Li Z, Zhang L. Use of antimicrobials in food animals and impact of transmission of antimicrobial resistance on humans. Biosaf Health. 2020. [Google Scholar]
  • 78.Vinayamohan PG, Pellissery AJ, Venkitanarayanan K. Role of horizontal gene transfer in the dissemination of antimicrobial resistance in food animal production. Curr Opin Food Sci. 2022;47:100882. doi: 10.1016/j.cofs.2022.100882 [DOI] [Google Scholar]
  • 79.Baker KS, Dallman TJ, Field N, Childs T, Mitchell H, Day M, et al. Horizontal antimicrobial resistance transfer drives epidemics of multiple Shigella species. Nat Commun. 2018;9(1):1462. doi: 10.1038/s41467-018-03949-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 80.Postma M, Vanderhaeghen W, Sarrazin S, Maes D, Dewulf J. Reducing antimicrobial usage in pig production without jeopardizing production parameters. Zoonoses Public Health. 2017;64(1):63–74. doi: 10.1111/zph.12283 [DOI] [PubMed] [Google Scholar]
  • 81.Harbarth S, Balkhy HH, Goossens H, Jarlier V, Kluytmans J, Laxminarayan R, et al. Antimicrobial resistance: one world, one fight! Antimicrob Resist Infect Control. 2015;4(1). doi: 10.1186/s13756-015-0091-2 [DOI] [Google Scholar]
  • 82.Donado-Godoy P, Castellanos R, León M, Arevalo A, Clavijo V, Bernal J, et al. The Establishment of the colombian integrated program for antimicrobial resistance surveillance (COIPARS): a pilot project on poultry farms, slaughterhouses and retail market. Zoonoses Public Health. 2015;62 Suppl 1:58–69. doi: 10.1111/zph.12192 [DOI] [PubMed] [Google Scholar]
  • 83.Ayukekbong JA, Ntemgwa M, Atabe AN. The threat of antimicrobial resistance in developing countries: causes and control strategies. Antimicrob Resist Infect Control. 2017;6:47. doi: 10.1186/s13756-017-0208-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 84.Berndtson AE. Increasing globalization and the movement of antimicrobial resistance between countries. Surg Infect (Larchmt). 2020;21(7):579–85. doi: 10.1089/sur.2020.145 [DOI] [PubMed] [Google Scholar]
  • 85.Holmes AH, Moore LSP, Sundsfjord A, Steinbakk M, Regmi S, Karkey A, et al. Understanding the mechanisms and drivers of antimicrobial resistance. Lancet. 2016;387(10014):176–87. doi: 10.1016/S0140-6736(15)00473-0 [DOI] [PubMed] [Google Scholar]
  • 86.Proroga Y, Mancusi A, Peruzy M, Carullo M, Montone A, Fulgione A. Characterization of Salmonella Typhimurium and its monophasic variant 1,4,[5],12:i:- isolated from different sources. Folia Microbiologica. 2019;64(6):711–8. doi: 10.1007/s12223-019-00683-6 [DOI] [PubMed] [Google Scholar]
  • 87.Hernández-Ledesma A, Cabrera-Díaz E, Arvizu-Medrano SM, Gómez-Baltazar A, Hernández-Iturriaga M, Godínez-Oviedo A, et al. Virulence and antimicrobial resistance profiles of Salmonella enterica isolated from foods, humans, and the environment in Mexico. Int J of Food Microbiol. 2023;391:110135. doi: 10.1016/j.ijfoodmicro.2023.110135 [DOI] [PubMed] [Google Scholar]
  • 88.Balasubramanian R, Im J, Lee J-S, Jeon HJ, Mogeni OD, Kim JH, et al. The global burden and epidemiology of invasive non-typhoidal Salmonella infections. Hum Vaccin Immunother. 2019;15(6):1421–6. doi: 10.1080/21645515.2018.1504717 [DOI] [PMC free article] [PubMed] [Google Scholar]
PLoS Negl Trop Dis. doi: 10.1371/journal.pntd.0012830.r002

Decision Letter 0

Stuart D Blacksell, Ahmed Hassan Fahal

20 Aug 2024

Dear Professor Chaparro-Gutierrez,

Thank you very much for submitting your manuscript "Genomic characterization of antimicrobial-resistant and virulence factors in Salmonella isolates obtained from pig farms in Antioquia, Colombia" for consideration at PLOS Neglected Tropical Diseases. As with all papers reviewed by the journal, your manuscript was reviewed by members of the editorial board and by several independent reviewers. In light of the reviews (below this email), we would like to invite the resubmission of a significantly-revised version that takes into account the reviewers' comments.

We cannot make any decision about publication until we have seen the revised manuscript and your response to the reviewers' comments. Your revised manuscript is also likely to be sent to reviewers for further evaluation.

When you are ready to resubmit, please upload the following:

[1] A letter containing a detailed list of your responses to the review comments and a description of the changes you have made in the manuscript. Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.

[2] Two versions of the revised manuscript: one with either highlights or tracked changes denoting where the text has been changed; the other a clean version (uploaded as the manuscript file).

Important additional instructions are given below your reviewer comments.

Please prepare and submit your revised manuscript within 60 days. If you anticipate any delay, please let us know the expected resubmission date by replying to this email. Please note that revised manuscripts received after the 60-day due date may require evaluation and peer review similar to newly submitted manuscripts.

Thank you again for your submission. We hope that our editorial process has been constructive so far, and we welcome your feedback at any time. Please don't hesitate to contact us if you have any questions or comments.

Sincerely,

Ahmed Hassan Fahal, FRCS, FRCSI, FRCSG, MS, MD, FRCP(London)

Academic Editor

PLOS Neglected Tropical Diseases

Stuart Blacksell

Section Editor

PLOS Neglected Tropical Diseases

***********************

Reviewer's Responses to Questions

Key Review Criteria Required for Acceptance?

As you describe the new analyses required for acceptance, please consider the following:

Methods

-Are the objectives of the study clearly articulated with a clear testable hypothesis stated?

-Is the study design appropriate to address the stated objectives?

-Is the population clearly described and appropriate for the hypothesis being tested?

-Is the sample size sufficient to ensure adequate power to address the hypothesis being tested?

-Were correct statistical analysis used to support conclusions?

-Are there concerns about ethical or regulatory requirements being met?

Reviewer #1: 1. Objectives and Hypothesis:

The aim of the study is clearly stated and no hypothesis is stated.

2. Study Design:

This design used was suitable for the purposes of achieving the intended objectives. However, the lack of a clear inclusion and exclusion criteria raises concerns about inference and generalisation of their findings.

3. Population Description/ sample size

The sample size determination is not clearly outlined, neither is the inclusion and exclusion criteria.

statistical analysis

Unfortunately, the submission is lacking in this aspect, the authors fail to describe much of the methodology used during their comparison between genotypic and phenotypic resistance.

4.Ethical or regulatory requirements

There are no concerns about ethical or regulatory requirements not being met. However, it might be helpful for them to include any supporting documents during their submission.

Reviewer #2: -Are the objectives of the study clearly articulated with a clear testable hypothesis stated?

Yes the objectives were well stated following the background about the study

-Is the study design appropriate to address the stated objectives?

Yes

-Is the population clearly described and appropriate for the hypothesis being tested?

Yes

- Is the sample size sufficient to ensure adequate power to address the hypothesis being tested?

There was no clear description of the type of sampling (purposive, random) and sample size estimation/ calculation that was carried out to detect resistant genotypes, and how this was used to obtain these study samples. The authors reported 653 samples collected from 11 towns in 3 years for which 28 were sequenced. The numbers reported here are low given the sampling frame and duration and hence a need to show clear validation from the sample size calculation.

-Were correct statistical analysis used to support conclusions?

Yes

-Are there concerns about ethical or regulatory requirements being met?

In addition of the institutional REC, wasn't their approval from the National research governing council? The details about the consent (sample collection, storage and data publishing) for the study is missing yet worth including in the manuscript.

--------------------

Results

-Does the analysis presented match the analysis plan?

-Are the results clearly and completely presented?

-Are the figures (Tables, Images) of sufficient quality for clarity?

Reviewer #1: With the specific example of the comparison of genotypic and phenotypic resistance resistance, no methodology was given for that particular result. The figures and tables are of sufficient quality.

Reviewer #2: -Does the analysis presented match the analysis plan?

Yes the analysis covers the analysis plan of the study objectives

-Are the results clearly and completely presented?

Yes

-Are the figures (Tables, Images) of sufficient quality for clarity?

Yes

--------------------

Conclusions

-Are the conclusions supported by the data presented?

-Are the limitations of analysis clearly described?

-Do the authors discuss how these data can be helpful to advance our understanding of the topic under study?

-Is public health relevance addressed?

Reviewer #1: The conclusions could be narrowed down to the specific findings of the study.

The limitations of the study are not described.

The authors attempt to discuss how their findings can be helpful in advancing our understanding of the topic under study and the public health relevance is addressed.

Reviewer #2: -Are the conclusions supported by the data presented?

Yes the discussion of the results and conclusion are well supported by the data

-Are the limitations of analysis clearly described?

The limitations on the sample size sequenced with respect to the site coverage was not described and yet this is worth mentioning

-Do the authors discuss how these data can be helpful to advance our understanding of the topic under study?

Yes

-Is public health relevance addressed?

Yes

--------------------

Editorial and Data Presentation Modifications?

<br/>

Use this section for editorial suggestions as well as relatively minor modifications of existing data that would enhance clarity. If the only modifications needed are minor and/or editorial, you may wish to recommend “Minor Revision” or “Accept”.

Reviewer #1: (No Response)

Reviewer #2: Methodology

Line 116. The statement, “A total of 28 isolates of Salmonella spp. were included”. This is somewhat misleading since the authors proceed with the sentence on “Fecal samples, rectal swabs and tissue samples…” Does this imply that 28 fecal, rectal swab and tissue samples were collected or 28 known isolates of Salmonella spp were added to the samples collected? There is a need to rephrase this paragraph for clarity on the sample collection. In addition, please be more specific about which “tissue” sample was collected, blood, skin? Also good to mention the time/ point of fecal sample collection, was it immediately after defecation? Was it obtained from the rectum?

Line 124. Again, which tissue was collected?

Line 132. It is worth mentioning the biochemical and serological confirmatory tests for Salmonella that were carried out on the isolates.

Results

Line 208. Describe the type of sampling (purposive, random) and sample size estimation calculation that was required to detect resistant genotypes, and how this was used to obtain these study samples. The 653 samples collected from 11 towns in 3 years seems few!

Line 210. The 28 representative samples, it is worth mentioning the sample source as indicated under the methodology sample collection section, for instance how many of these 28 isolates were collected from fecal, rectal swab or tissue.

Line 219. The context under this subsection involved comparison of the Typimurium isolates from this study with global isolates from Enterobase database. I suggest the subsection heading is changed to “comparison with global serovar Typhimurium isolates”

Line 270. Change sub title to “identification of antimicrobial resistance genes”

Line 322. When comparing phenotypic and genotypic resistant isolates, the authors mention correlation analysis however there is no correlation coefficients nor r-squared values given to support the claims. Support the term “discrepancy” with the correlation coefficient values for the comparison.

--------------------

Summary and General Comments

Use this section to provide overall comments, discuss strengths/weaknesses of the study, novelty, significance, general execution and scholarship. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. If requesting major revision, please articulate the new experiments that are needed.

Reviewer #1: * The study should have a clear justification for the sample size determined (i.e is the study adequately powered? was the sampling purposive?).

* The sample inclusion and exclusion criteria should be clearly articulated along with any statistical implications.

* The methodology for any statistical comparisons should be clearly stated (genotypic resistance vs phenotypic resistance).

Reviewer #2: (No Response)

--------------------

PLOS authors have the option to publish the peer review history of their article (what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy .

Reviewer #1: Yes: Kimuda Magambo Phillip

Reviewer #2: No

Figure Files:

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org.

Data Requirements:

Please note that, as a condition of publication, PLOS' data policy requires that you make available all data used to draw the conclusions outlined in your manuscript. Data must be deposited in an appropriate repository, included within the body of the manuscript, or uploaded as supporting information. This includes all numerical values that were used to generate graphs, histograms etc.. For an example see here: http://www.plosbiology.org/article/info%3Adoi%2F10.1371%2Fjournal.pbio.1001908#s5.

Reproducibility:

To enhance the reproducibility of your results, we recommend that you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option to publish peer-reviewed clinical study protocols. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols

Attachment

Submitted filename: Reviewer report.pdf

pntd.0012830.s002.pdf (76.1KB, pdf)
PLoS Negl Trop Dis. doi: 10.1371/journal.pntd.0012830.r004

Decision Letter 1

Stuart D Blacksell, Ahmed Hassan Fahal

21 Oct 2024

Dear Professor Chaparro-Gutierrez,

Thank you very much for submitting your manuscript "Genomic characterization of antimicrobial-resistance and virulence factors in Salmonella isolates obtained from pig farms in Antioquia, Colombia" for consideration at PLOS Neglected Tropical Diseases. As with all papers reviewed by the journal, your manuscript was reviewed by members of the editorial board and by several independent reviewers. In light of the reviews (below this email), we would like to invite the resubmission of a significantly-revised version that takes into account the reviewers' comments.

We cannot make any decision about publication until we have seen the revised manuscript and your response to the reviewers' comments. Your revised manuscript is also likely to be sent to reviewers for further evaluation.

When you are ready to resubmit, please upload the following:

[1] A letter containing a detailed list of your responses to the review comments and a description of the changes you have made in the manuscript. Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.

[2] Two versions of the revised manuscript: one with either highlights or tracked changes denoting where the text has been changed; the other a clean version (uploaded as the manuscript file).

Important additional instructions are given below your reviewer comments.

Please prepare and submit your revised manuscript within 60 days. If you anticipate any delay, please let us know the expected resubmission date by replying to this email. Please note that revised manuscripts received after the 60-day due date may require evaluation and peer review similar to newly submitted manuscripts.

Thank you again for your submission. We hope that our editorial process has been constructive so far, and we welcome your feedback at any time. Please don't hesitate to contact us if you have any questions or comments.

Sincerely,

Ahmed Hassan Fahal, FRCS, FRCSI, FRCSG, MS, MD, FRCP(London)

Academic Editor

PLOS Neglected Tropical Diseases

Stuart Blacksell

Section Editor

PLOS Neglected Tropical Diseases

***********************

Figure Files:

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org.

Data Requirements:

Please note that, as a condition of publication, PLOS' data policy requires that you make available all data used to draw the conclusions outlined in your manuscript. Data must be deposited in an appropriate repository, included within the body of the manuscript, or uploaded as supporting information. This includes all numerical values that were used to generate graphs, histograms etc.. For an example see here: http://www.plosbiology.org/article/info%3Adoi%2F10.1371%2Fjournal.pbio.1001908#s5.

Reproducibility:

To enhance the reproducibility of your results, we recommend that you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option to publish peer-reviewed clinical study protocols. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols

PLoS Negl Trop Dis. doi: 10.1371/journal.pntd.0012830.r006

Decision Letter 2

Stuart D Blacksell, Ahmed Hassan Fahal

8 Jan 2025

Dear Professor Chaparro-Gutierrez,

We are pleased to inform you that your manuscript 'Genomic characterization of antimicrobial-resistance and virulence factors in Salmonella isolates obtained from pig farms in Antioquia, Colombia' has been provisionally accepted for publication in PLOS Neglected Tropical Diseases.

Before your manuscript can be formally accepted you will need to complete some formatting changes, which you will receive in a follow up email. A member of our team will be in touch with a set of requests.

Please note that your manuscript will not be scheduled for publication until you have made the required changes, so a swift response is appreciated.

IMPORTANT: The editorial review process is now complete. PLOS will only permit corrections to spelling, formatting or significant scientific errors from this point onwards. Requests for major changes, or any which affect the scientific understanding of your work, will cause delays to the publication date of your manuscript.

Should you, your institution's press office or the journal office choose to press release your paper, you will automatically be opted out of early publication. We ask that you notify us now if you or your institution is planning to press release the article. All press must be co-ordinated with PLOS.

Thank you again for supporting Open Access publishing; we are looking forward to publishing your work in PLOS Neglected Tropical Diseases.

Best regards,

Ahmed Hassan Fahal, FRCS, FRCSI, FRCSG, MS, MD, FRCP(London)

Academic Editor

PLOS Neglected Tropical Diseases

Stuart Blacksell

Section Editor

PLOS Neglected Tropical Diseases

Shaden Kamhawi

co-Editor-in-Chief

PLOS Neglected Tropical Diseases

orcid.org/0000-0003-4304-636XX

Paul Brindley

co-Editor-in-Chief

PLOS Neglected Tropical Diseases

orcid.org/0000-0003-1765-0002

***********************************************************

Reviewer's Responses to Questions

Key Review Criteria Required for Acceptance?

As you describe the new analyses required for acceptance, please consider the following:

Methods

-Are the objectives of the study clearly articulated with a clear testable hypothesis stated?

-Is the study design appropriate to address the stated objectives?

-Is the population clearly described and appropriate for the hypothesis being tested?

-Is the sample size sufficient to ensure adequate power to address the hypothesis being tested?

-Were correct statistical analysis used to support conclusions?

-Are there concerns about ethical or regulatory requirements being met?

Reviewer #1: The authors included recommendations such as an ethical approval statement, details on WGS and making their raw sequence data publicly accessible.

**********

Results

-Does the analysis presented match the analysis plan?

-Are the results clearly and completely presented?

-Are the figures (Tables, Images) of sufficient quality for clarity?

Reviewer #1: The recommendation below was not adequately addressed. Granted the authors included Table 2 which helps a lot, however the statistical comparisons would add value.

The authors could consider carrying out a correlation analysis between the occurrence of antimicrobial resistance genes (genotypic resistance) and resistant phenotypes from the antimicrobial susceptibility testing (e.g., chi-square tests for categorical data).

**********

Conclusions

-Are the conclusions supported by the data presented?

-Are the limitations of analysis clearly described?

-Do the authors discuss how these data can be helpful to advance our understanding of the topic under study?

-Is public health relevance addressed?

Reviewer #1: The conclusion is adequate.

**********

Editorial and Data Presentation Modifications?

Use this section for editorial suggestions as well as relatively minor modifications of existing data that would enhance clarity. If the only modifications needed are minor and/or editorial, you may wish to recommend “Minor Revision” or “Accept”.

Reviewer #1: The recommendation below was not adequately addressed. Granted the authors included Table 2 which helps a lot, however the statistical comparisons would add value.

The authors could consider carrying out a correlation analysis between the occurrence of antimicrobial resistance genes (genotypic resistance) and resistant phenotypes from the antimicrobial susceptibility testing (e.g., chi-square tests for categorical data).

**********

Summary and General Comments

Use this section to provide overall comments, discuss strengths/weaknesses of the study, novelty, significance, general execution and scholarship. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. If requesting major revision, please articulate the new experiments that are needed.

Reviewer #1: (No Response)

**********

PLOS authors have the option to publish the peer review history of their article (what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy .

Reviewer #1: No

PLoS Negl Trop Dis. doi: 10.1371/journal.pntd.0012830.r007

Acceptance letter

Ahmed Fahal

Dear Professor Chaparro-Gutierrez,

We are delighted to inform you that your manuscript, "Genomic characterization of antimicrobial-resistance and virulence factors in Salmonella isolates obtained from pig farms in Antioquia, Colombia," has been formally accepted for publication in PLOS Neglected Tropical Diseases.

We have now passed your article onto the PLOS Production Department who will complete the rest of the publication process. All authors will receive a confirmation email upon publication.

The corresponding author will soon be receiving a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any scientific or type-setting errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript. Note: Proofs for Front Matter articles (Editorial, Viewpoint, Symposium, Review, etc...) are generated on a different schedule and may not be made available as quickly.

Soon after your final files are uploaded, the early version of your manuscript will be published online unless you opted out of this process. The date of the early version will be your article's publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers.

Thank you again for supporting open-access publishing; we are looking forward to publishing your work in PLOS Neglected Tropical Diseases.

Best regards,

Shaden Kamhawi

co-Editor-in-Chief

PLOS Neglected Tropical Diseases

Paul Brindley

co-Editor-in-Chief

PLOS Neglected Tropical Diseases

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Fig. Serovar Typhimurium isolates from swine form two distinct clusters.

    All Salmonella serovar Typhimurium isolates from swine in the Enterobase database are shown on a GrapeTree plot using cgMLST profiles to show phylogenetic distance. White circles highlighted in red are isolates from this study. (Scale bar) Number of cgMLST pairwise allelic differences (PADs).”Missing” on the figure legend indicates the country of sample origin was not included in the metadata for included samples.

    (TIF)

    pntd.0012830.s001.tif (1.2MB, tif)
    Attachment

    Submitted filename: Reviewer report.pdf

    pntd.0012830.s002.pdf (76.1KB, pdf)
    Attachment

    Submitted filename: Rebuttal letter Plos Tropical Disease October.docx

    pntd.0012830.s004.docx (16.3KB, docx)
    Attachment

    Submitted filename: Rebuttal letter PlosOne R&E.docx

    pntd.0012830.s005.docx (32.8KB, docx)

    Data Availability Statement

    All WGS data supporting the findings of this study have been deposited in the National Center for Biotechnology Information (NCBI) Sequence Read Archive under BioProject ID PRJNA1168507.


    Articles from PLOS Neglected Tropical Diseases are provided here courtesy of PLOS

    RESOURCES